Targeting TGFβ docking receptor glycoprotein A repetitions predominant (GARP) via novel chimeric antigen receptor (CAR)-T cell platform to treat glioblastoma.

Wu BX, Kreatsoulas D, Cam H, Bolyard C, Chang Y, Mandula J, Welsh PW, Wang Z, Li A, Weltge P, Reynolds K, Amankwah Y, Elder JB, Giglio P, Otero JJ, Rajappa P, Gerald D, Chung D, Ma Q, Velegraki M, Li Z

Open source

DOI
10.1093/neuonc/noaf195
Published
2025 Dec 1
Container
Neuro-oncology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/neuonc/noaf195,
  title = {Targeting TGFβ docking receptor glycoprotein A repetitions predominant (GARP) via novel chimeric antigen receptor (CAR)-T cell platform to treat glioblastoma.},
  author = {Wu BX and Kreatsoulas D and Cam H and Bolyard C and Chang Y and Mandula J and Welsh PW and Wang Z and Li A and Weltge P and Reynolds K and Amankwah Y and Elder JB and Giglio P and Otero JJ and Rajappa P and Gerald D and Chung D and Ma Q and Velegraki M and Li Z},
  year = {2025},
  journal = {Neuro-oncology},
  doi = {10.1093/neuonc/noaf195},
  url = {https://doi.org/10.1093/neuonc/noaf195}
}

RIS

TY  - JOUR
TI  - Targeting TGFβ docking receptor glycoprotein A repetitions predominant (GARP) via novel chimeric antigen receptor (CAR)-T cell platform to treat glioblastoma.
AU  - Wu BX
AU  - Kreatsoulas D
AU  - Cam H
AU  - Bolyard C
AU  - Chang Y
AU  - Mandula J
AU  - Welsh PW
AU  - Wang Z
AU  - Li A
AU  - Weltge P
AU  - Reynolds K
AU  - Amankwah Y
AU  - Elder JB
AU  - Giglio P
AU  - Otero JJ
AU  - Rajappa P
AU  - Gerald D
AU  - Chung D
AU  - Ma Q
AU  - Velegraki M
AU  - Li Z
PY  - 2025
JO  - Neuro-oncology
DO  - 10.1093/neuonc/noaf195
UR  - https://doi.org/10.1093/neuonc/noaf195
ER  - 

APA

BX, W., D, K., H, C., C, B., Y, C., J, M., PW, W., Z, W., A, L., P, W., K, R., Y, A., JB, E., P, G., JJ, O., P, R., D, G., D, C., Q, M., M, V., & Z, L. (2025). Targeting TGFβ docking receptor glycoprotein A repetitions predominant (GARP) via novel chimeric antigen receptor (CAR)-T cell platform to treat glioblastoma.. Neuro-oncology. https://doi.org/10.1093/neuonc/noaf195

Source records